Patients With Esrd Disease, The Direct Economic Burden Of Survey Research

Research purposesBased on the three types of direct economic burden of RRT, expect to find in the existing medical insurance compensation system deficiencies, and this lack of access to optimal treatment of patients influence the final recommendations presented to the compensation policy of health insurance proposals reflect the results.Object of study and methodsThe questionnaire to the context of Panyu District, Medicare patients with end-stage renal disease as the target.1.This study investigated the way, including on-site survey, telephone interviews and surveys among households of three parts. On the study of socio-demographic characteristics, disease diagnosis, treatment and utilization of medical services, the financial burden of the disease were investigated.2.The questionnaire used by praying Hospital of Guangzhou University of Chinese Medicine Centre experts repeatedly demonstrated by kidney questionnaire. This take SPSS 17.0 software data entry and analysis.Results1. Study investigating the direct economic burden of disease both in the number of different age group had a statistically significant difference in income and an alternative treatment choice was not statistically different.2. Western charges in kidney transplantation study of direct medical costs are the main factors affecting the degree of influence is very high, followed by treatment costs. Choose a different alternative treatment of subjects of non-direct medical costs there is no statistically significant difference.3. Different study alternative treatment for loss of income differences between individuals no significant loss of income among family members, the difference was not statistically significant. Hemodialysis and peritoneal dialysis study loss of personal income greater than the income losses of family members.4. Different alternative therapies in treating disease impact on the family aspects of the economy was no significant difference in the extent of use of loan or savings, other economic plans to postpone the degree of difference was statistically significant.Choose peritoneal dialysis study in the use of the degree of borrowing or savings and other economic plans to postpone serious highest degree, followed by the selection of hemodialysis study.Conclusions1. End-stage renal disease consumes a large amount of health economic resources.Panyu Health Insurance Fund of patients with end stage renal bear the high cost of a younger age use of health resources to extend the time. Recommended for younger age, strengthening the treatment of renal graft substitutes propaganda.2. End-stage renal disease patients and families to bring enormous economic pressure. Study will be to individuals and family members on the loss of income replacement therapy affect the smaller tilt. Family and personal spending pressure is different alternative forms of treatment effectiveness-the cost in line. Recommended the introduction of new technology on peritoneal dialysis, peritoneal dialysis patients to improve technology and understanding of the cost.3. With end stage renal replacement therapy in patients with different ways the composition of the direct medical costs, medicine costs are the main factors.Proposal to increase Medicare reimbursement for end-stage renal disease drugs can be areas, the establishment of Medicare patients in drug monitoring system for the regular use of drugs is not in the scope of Medicare's hospital reimbursement control.